Currently out of the existing stock ratings of Richard Newitter, 410 are a BUY (59.51%), 279 are a HOLD (40.49%).

Richard Newitter

Work Performance Price Targets & Ratings Chart

Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 64.16% that have a potential upside of 21.37% achieved within 267 days.

Richard Newitter’s has documented 1,414 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Financial Services, Technology, Communication Services sectors.

Most recent stock forecast was given on DXCM, DexCom at 31-Jul-2026.

Wall Street Analyst Richard Newitter

Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 11/24/2025. The price target of $128 was fulfilled within 1 day with a profit of $10.71 (9.13%) receiving and performance score of 91.31.

Average potential price target upside

of $66.76 (58.61%) on BDX (BECTON DICKINSON AND COMPANY).
of $40.14 (100.81%) on AX (AXOS FINANCIAL).
of $39.4 (24.45%) on INSP (INSPIRE MEDICAL SYSTEMS).

ALC Alcon AG ALGN Align Technology AXGN Axogen BDX Becton Dickinson and Company GMED Globus Medical HOLX Hologic INSP Inspire Medical Systems ISRG Intuitive Surgical ITMR Itamar Medical Ltd LNTH Lantheus Holdings NUVA NuVasive SIEN Sientra SYK Stryker TFX Teleflex XENT Intersect ENT ZBH Zimmer Biomet Holdings AXNX Axonics Modulation Technologies CNMD CONMED IART Integra LifeSciences Holdings MDT Medtronic PLC WMGI Wright Medical Group N.V EW Edwards Lifesciences Corp NARI Inari Medical SPNE SeaSpine Holdings Corp BSX Boston Scientific Corp KIDS Orthopediatrics Corp NVRO Nevro Corp PRCT Procept Biorobotics Corp TMCI Treace Medical Concepts IRTC iRhythm Technologies GKOS Glaukos Corp IRT Independence Realty Trust ITGR Integer Holdings Corp PEN Penumbra VCEL Vericel Corp Ord DXCM DexCom PODD Insulet TNDM Tandem Diabetes Care AX Axos Financial IT Gartner LNSR ORGO Organogenesis Holdings RXST Rxsight SIBN Si-Bone WMG Warner Music Group

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Anthony Petrone (MIZUHO)